(Q55462196)

12 July 2018

title

MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET? (English)

1 reference

12 July 2018

magnetic resonance imaging

main subject

0 references

author

Christian la Fougère

11

1 reference

12 July 2018

Peter Bartenstein

8

Peter Bartenstein

1 reference

12 July 2018

Paul Cumming

7

Paul Cumming

1 reference

12 July 2018

Nathalie L Jansen

1

Nathalie L Jansen

1 reference

12 July 2018

Friedrich-Wilhelm Kreth

10

Friedrich Wilhelm Kreth

1 reference

12 July 2018

Vera Graute

2

Vera Graute

1 reference

12 July 2018

Sabina Eigenbrod

6

Sabina Eigenbrod

1 reference

12 July 2018

Bogdana Suchorska

4

Bogdana Suchorska

1 reference

12 July 2018

Juergen Lutz

5

Juergen Lutz

1 reference

12 July 2018

Jörg-Christian Tonn

9

Jörg-Christian Tonn

1 reference

12 July 2018

author name string

Lena Armbruster

3

1 reference

12 July 2018

publication date

11 April 2012

1 reference

12 July 2018

European Journal of Nuclear Medicine and Molecular Imaging

published in

1 reference

12 July 2018

volume

39

1 reference

12 July 2018

issue

6

1 reference

12 July 2018

page(s)

1021-1029

1 reference

12 July 2018

The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: histopathological evaluation of a series

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

How often are nonenhancing supratentorial gliomas malignant? A population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

Value of O-(2-[18F]fluoroethyl)- L-tyrosine PET for the diagnosis of recurrent glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

Positron emission tomography with O-(2-[18F]fluoroethyl)-l-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

O-(2-[18F]fluoroethyl)-L-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

FET-PET for malignant glioma treatment planning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

Hot spots in dynamic (18)FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

Evaluation of primary brain tumors using 11C-methionine PET with reference to a normal methionine uptake map.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

11C-methionine PET for differential diagnosis of low-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

Association of F18-fluoro-ethyl-tyrosin uptake and 5-aminolevulinic acid-induced fluorescence in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

The quantification of dynamic FET PET imaging and correlation with the clinical outcome in patients with glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

Methyl-L-11C-methionine PET as a diagnostic marker for malignant progression in patients with glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

Assessment of various strategies for 18F-FET PET-guided delineation of target volumes in high-grade glioma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

Molecular imaging of gliomas with PET: opportunities and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

The preparation of 11C-methyl iodide and its use in the synthesis of 11C-methyl-L-methionine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

Comparison of fluorotyrosines and methionine uptake in F98 rat gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

Comparison of F-18 FET-PET with F-18 FDG-PET for biopsy planning of non-contrast-enhancing gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

18F-FET PET for planning of thermotherapy using magnetic nanoparticles in recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

A biologically adapted dose-escalation approach, demonstrated for 18F-FET-PET in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

[(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

Serial O-(2-[(18)F]fluoroethyl)-L: -tyrosine PET for monitoring the effects of intracavitary radioimmunotherapy in patients with malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

New advances that enable identification of glioblastoma recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

O-(2-18F-fluoroethyl)-L-tyrosine PET predicts failure of antiangiogenic treatment in patients with recurrent high-grade glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

Prognostic value of O-(2-18F-fluoroethyl)-L-tyrosine PET and MRI in low-grade glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

Prognostic value of 18F-fluoroethyl-L-tyrosine PET and MRI in small nonspecific incidental brain lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

Is there a place for FET PET in the initial evaluation of brain lesions with unknown significance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

Prediction of pathology and survival by FDG PET in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

Methyl-[11C]-l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

Contributions of biological tumor parameters to the incorporation rate of L: -[methyl-(11)C] methionine into astrocytomas and oligodendrogliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

(18)F-FDG and (18)F-FET uptake in experimental soft tissue infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

O-(2-[(18)F]Fluoroethyl)- L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

Differential uptake of [18F]FET and [3H]l-methionine in focal cortical ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

Differential uptake of O-(2-18F-fluoroethyl)-L-tyrosine, L-3H-methionine, and 3H-deoxyglucose in brain abscesses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2109-9

18F-FET PET differentiation of ring-enhancing brain lesions.

21 January 2018

1 reference

12 December 2020

Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma

1 reference

12 December 2020

Re-evaluation of amino acid PET studies: can the protein synthesis rates in brain and tumor tissues be measured in vivo?

1 reference

12 December 2020

Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods?

1 reference

12 December 2020

Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors.

1 reference

12 December 2020

Increased amino acid transport into brain tumors measured by PET of L-(2-18F)fluorotyrosine

1 reference

12 December 2020

Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging.

1 reference

12 December 2020

10.1007/S00259-012-2109-9

Identifiers

DOI

1 reference

12 July 2018

Dimensions Publication ID

1035723782

0 references

1 reference

12 July 2018